நீல் மகாபத்ரா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நீல் மகாபத்ரா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நீல் மகாபத்ரா Today - Breaking & Trending Today

Medical cannabis company backed by Snoop Dogg launches on London Stock Exchange


CNBC that the money raised from the IPO will go towards developing four new drugs.
“The key here is about getting cannabinoids into the hands of patients and the way you do that is through the drug development process,” Lucas said.
“The medical cannabis, the problem with that is that physicians cannot prescribe it, so we want a drug product that we can get into the hands of physicians, into the hands of patients,” he added.
Two of the company’s drug products will be heading into clinical trials following the IPO. According to
Proactive Investors, OCT has a proprietary library of 93 cannabinoid derivatives. ....

United States , City Of , United Kingdom , Snoop Dogg , Neil Mahapatra , John Lucas , London Stock Exchange , Casa Verde Capital , Cannabinoid Technologies , London Stock , Imperial Brands , ஒன்றுபட்டது மாநிலங்களில் , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , ஸ்னூப் நாய் , நீல் மகாபத்ரா , ஜான் லூகாஸ் , லண்டன் ஸ்டாக் பரிமாற்றம் , காசா வர்டீ மூலதனம் , கன்னாபினாய்டு தொழில்நுட்பங்கள் , லண்டன் ஸ்டாக் , ஏகாதிபத்தியம் பிராண்டுகள் ,

Oxford Cannabinoid Technologies to list in London 'to further four drug development programs'


Oxford Cannabinoid Technologies to list in London to further four drug development programs
Oxford Cannabinoid Technologies Holdings Ltd s co-founder and executive chairman Neil Mahapatra talks to Proactive London ahead of their London initial public offer on Friday 21st May. 
The firm have raised £16.5mln to develop cannabis-based pain treatments and are expected to reach a valuation on listing of around £51mln.
With the company focussed on medicines that mimic the painkilling effects of cannabis, it plans to use the funds raised in the IPO to help develop a portfolio of four drug candidates for approval as licensed pain medicines, with the aim of commercializing the company s first drug in 2027. ....

City Of , United Kingdom , Neil Mahapatra , Oxford Cannabinoid Technologies Holdings Ltd , Proactive London , Director Interviews , Harma Biotech , Oxford Cannabinoid Technologies Holdings Plc , Rivate Uk Octl , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , நீல் மகாபத்ரா , ப்ரோவாக்டிவ் லண்டன் , இயக்குனர் நேர்காணல்கள் ,